This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 27 Aug 2020  |  Global  |  Market Research

    Smart Labs as Key Drivers for the Digital Transformation of Diagnostic Laboratories, 2020

    Robotic Automation, Internet of Things (IoT), and Artificial Intelligence (AI) Offering Growth Opportunities for Academic and Commercial Diagnostics Labs

    Diagnostic academic and commercial research labs suffer from cost pressures, given the ongoing Protecting Access to Medicare Act (PAMA) regulations and reproducibility issues, and are under productivity strain. The recent COVID-19 pandemic leading to increasing test volumes and renewed focus on research and development (R&D) to drive innovation wil...

    $3,000.00
  2. 27 Jan 2020  |  Global  |  Market Research

    Growth Opportunities—Contract Manufacturing and Outsourcing Opportunities in the In-vitro Diagnostics (IVD) Industry, 2019 to 2022

    Consolidation and Innovative Business Models Will Accelerate IVD Outsourcing Growth

    The increasing pressure for cost-driven development and regulatory and regional trends are inducing industry participants to adopt innovative integrated business models so as to align themselves as one-stop-shop solution providers as opposed to the traditional functional service providers, thereby, creating a mutually beneficial symbiotic relations...

    $4,950.00
  3. 19 Dec 2016  |  Global  |  Customer Research

    Global Laboratory Products Purchasing Trends, 2016–2017

    An End-user Perspective on the Purchasing Process, Product Budgets, and Top Companies for Laboratory Products

    Readers of Lab Manager Magazine were invited to participate in an online survey in July 2016. To qualify for survey participation, readers had to play a role in their laboratory’s purchasing process, be familiar with their laboratory’s product budgets, and represent a laboratory that either uses or plans to use products in 1 or more of the 7 sp...

    $6,000.00
  4. 30 Jun 2016  |  Global  |  Market Research

    Growth and Expansion of Regenerative Medicine Market

     

    The market for regenerative medicine, one of the fastest growing segments in the biotechnology industry, is estimated to reach $67.5 billion by 2020 recording a compound annual growth rate (CAGR) of 22%. Current industry trends signal the expanding horizons of regenerative medicine, with its application being explored in new therapeutic segments su...

    $1,500.00
  5. 30 Jun 2016  |  Global  |  Market Research

    Global Immunoglobulin Therapeutics Market

     

    Immunoglobulin (Ig) therapies are among the oldest therapeutic moieties employed in a broad range of pathological conditions. Immunoglobulin G (IgG) holds the highest share (44%) in the global blood plasma market, with a revenue of $9.24 billion. Currently, the global Ig market is dominated by three major companies, holding about 85% of the total m...

    $1,500.00
  6. 30 Jun 2016  |  Global  |  Market Research

    Vital Signs The Analyst's Perspective - May 2016 Issue

    This Vital Signs issue discusses Sinocare's acquisition of PTS Diagnostics, biosimilar drug pricing, Americans' usage of prescription pain killers, and Takara Bio's acquistion of Wafergen Bio-systems.

    $450.00
  7. 27 Jun 2016  |  Global  |  Market Research

    Market Assessment of MRI Equipment and its Emerging Clinical Applications

    The global MRI market is currently experiencing steady growth (mid-single digit growth rate). Although economic uncertainty and budgetary constraints have slowed down the market in certain countries, technological innovation and extended/new clinical applications of MRI due to their high importance in the imaging space have enabled it to overcome t...

    $4,950.00
  8. 05 May 2016  |  Global  |  Market Research

    Future of Global Retail Healthcare Delivery Markets, Forecast to 2022

    Escalating Demand for Low-cost Alternatives to Create Market Size of Nearly $4 Billion

    Retail healthcare entails primary care services for minor illnesses provided through clinics located in retail environments, such as a pharmacies, grocery chains, supermarkets, or departmental stores. These retail care clinics, also called convenient care clinics, walk-in clinics, or in-store clinics, are often open beyond regular operating hours o...

    $3,000.00
  9. 04 Apr 2016  |  Global  |  Market Research

    Vital Signs - Emerging Trends and Opportunities in Life Sciences, February 2016

    Exciting Developments in Generic Drug Pricing, CRISPR Technology, GenomeAsia 100K and Large-scale Next-generation Sequencing Projects, and Medicare Outcomes

    This Vital Signs issues discusses generic drug pricing, CRISPR technology, GenomeAsia 100K and large-scale next-generation sequencing projects, and Medicare outcomes target.

    $450.00
  10. 29 Mar 2016  |  Global  |  Market Research

    Top 50 Emerging Technologies: Growth Opportunities of Strategic Imperative

    Multi-billion dollar technologies ready to propel industries and transform our world

    Research Overview The Top 50 Emerging Technologies research is a comprehensive analysis of the most promising and disruptive technologies poised to impact our world in the next few years. It highlights and offers strategic guidance and actionable ideas on the hottest 50 technologies that pack maximum potential to fuel global innovation; spawn in...

    $7,500.00